Literature DB >> 16369798

Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.

Terho Heikkinen1, Robert Booy, Magda Campins, Adam Finn, Per Olcén, Heikki Peltola, Carlos Rodrigo, Heinz-Josef Schmitt, Fabian Schumacher, Stephen Teo, Catherine Weil-Olivier.   

Abstract

Influenza is often regarded as an illness of the elderly portion of the population because most of the excess mortality associated with influenza epidemics occurs in that age group. However, evidence derived from a large number of clinical studies carried out in different countries and various settings has clearly demonstrated that the burden of influenza is also substantial in children. The attack rates of influenza during annual epidemics are consistently highest in children, and young children are hospitalized for influenza-related illnesses at rates comparable to those for adults with high-risk conditions. Especially among children younger than 3 years of age, influenza frequently predisposes the patient to bacterial complications such as acute otitis media. Children also serve as the main transmitters of influenza in the community. A safe and effective vaccine against influenza has been available for decades, but the vaccine is rarely used even for children with high-risk conditions. Despite several existing problems related to influenza vaccination of children, the current evidence indicates that the advantages of vaccinating young children would clearly outweigh the disadvantages. Considering the total burden of influenza in children, children younger than 3 years of age should be regarded as a high-risk group for influenza, analogously with the age-based definition of high risk among persons 65 years of age or older. Annual influenza vaccination should be recommended to all children from 6 months to 3 years of age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369798     DOI: 10.1007/s00431-005-0040-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  57 in total

1.  Impact of respiratory virus infections on persons with chronic underlying conditions.

Authors:  W P Glezen; S B Greenberg; R L Atmar; P A Piedra; R B Couch
Journal:  JAMA       Date:  2000-01-26       Impact factor: 56.272

2.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

3.  Predictors of influenza virus vaccination status in hospitalized children.

Authors:  K A Poehling; T Speroff; R S Dittus; M R Griffin; G B Hickson; K M Edwards
Journal:  Pediatrics       Date:  2001-12       Impact factor: 7.124

4.  Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.

Authors:  K M Neuzil; W D Dupont; P F Wright; K M Edwards
Journal:  Pediatr Infect Dis J       Date:  2001-08       Impact factor: 2.129

5.  The Japanese experience with vaccinating schoolchildren against influenza.

Authors:  T A Reichert; N Sugaya; D S Fedson; W P Glezen; L Simonsen; M Tashiro
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

6.  Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.

Authors:  E S Hurwitz; M Haber; A Chang; T Shope; S T Teo; J S Giesick; M M Ginsberg; N J Cox
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

7.  Safety of the trivalent inactivated influenza vaccine among children: a population-based study.

Authors:  Eric K France; Jason M Glanz; Stanley Xu; Robert L Davis; Steven B Black; Henry R Shinefield; Kenneth M Zangwill; S Michael Marcy; John P Mullooly; Lisa A Jackson; Robert Chen
Journal:  Arch Pediatr Adolesc Med       Date:  2004-11

8.  Influenza vaccination in the prevention of acute otitis media in children.

Authors:  T Heikkinen; O Ruuskanen; M Waris; T Ziegler; M Arola; P Halonen
Journal:  Am J Dis Child       Date:  1991-04

9.  Influenza A community-acquired pneumonia in East London infants and young children.

Authors:  Matthew Laundy; Ekundayo Ajayi-Obe; Khidir Hawrami; Celia Aitken; Judith Breuer; Robert Booy
Journal:  Pediatr Infect Dis J       Date:  2003-10       Impact factor: 2.129

10.  Influenza-associated acute encephalopathy in Japanese children in 1994-2002.

Authors:  Takehiro Togashi; Yoshihiro Matsuzono; Mitsuo Narita; Tsuneo Morishima
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

View more
  16 in total

1.  We will have to vaccinate healthy children against influenza when we know that it is helpful.

Authors:  Luis Moral; Eva María Rubio
Journal:  Eur J Pediatr       Date:  2006-05-25       Impact factor: 3.183

2.  Should healthy children be vaccinated against influenza? Comments about this query.

Authors:  Lucien Corbeel
Journal:  Eur J Pediatr       Date:  2006-09-29       Impact factor: 3.183

3.  Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Authors:  R Bodewes; G de Mutsert; F R M van der Klis; M Ventresca; S Wilks; D J Smith; M Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

4.  Admission diagnoses of children 0-16 years of age hospitalized with influenza.

Authors:  H Silvennoinen; V Peltola; R Vainionpää; O Ruuskanen; T Heikkinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-04       Impact factor: 3.267

5.  Clinical and socioeconomic impact of moderate-to-severe versus mild influenza in children.

Authors:  T Heikkinen; H Silvennoinen; S Heinonen; T Vuorinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-16       Impact factor: 3.267

6.  Signs and symptoms predicting influenza in children: a matched case-control analysis of prospectively collected clinical data.

Authors:  S Heinonen; V Peltola; H Silvennoinen; T Vahlberg; T Heikkinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-13       Impact factor: 3.267

Review 7.  The impact of influenza on working days lost: a review of the literature.

Authors:  Martin Keech; Paul Beardsworth
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  Controlling influenza by cytotoxic T-cells: calling for help from destroyers.

Authors:  Michael Schotsaert; Lorena Itatí Ibañez; Walter Fiers; Xavier Saelens
Journal:  J Biomed Biotechnol       Date:  2010-05-24

Review 9.  Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children.

Authors:  Vytautas Usonis; Ioana Anca; Francis André; Roman Chlibek; Inga Ivaskeviciene; Atanas Mangarov; Zsófia Mészner; Roman Prymula; Pavol Simurka; Eda Tamm; Goran Tesović
Journal:  BMC Infect Dis       Date:  2010-06-14       Impact factor: 3.090

10.  Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Chantal Baas; Martina M Geelhoed-Mieras; Gerrie de Mutsert; Geert van Amerongen; Judith M A van den Brand; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  PLoS One       Date:  2009-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.